EO2 Concepts announced the release of an enhanced version of their full wound closure, at-home therapy system. The upgrade of the system consists of new and improved features for both the medical device, called the OxyGeni, and the OxySpur wound dressings.
The OxyGeni and the OxySpur Oxygen Diffusion Dressings combine to provide a standalone, full wound closure system that provides continuous diffusion of oxygen (CDO) therapy, a company press release states. The system provides advanced wound care therapy, a continuous (24/7) flow of pure humidified oxygen that is silent and can be worn by the patient. CDO therapy with this system may offer full closure and pain relief to patients suffering with chronic wounds, including diabetic and other healing-compromised patients. The upgrades to the system will allow many patients at high risk for COVID-19 to stay at home, while still receiving an advanced oxygen treatment prescribed by physicians using new telehelath programmes.
The OxyGeni replaces the TransCu O2. The OxyGeni uses a micro USB charger. Every patient will receive a micro USB battery pack to enable the patient to receive therapy on the move, as they will have the ability to charge anywhere at any time. The battery life has been extended to over 48 hours, with EO2 Concepts claiming that the upgraded device also offers improved accuracy of the battery status and the management of the charging function. The OxyGeni also comes with a choice of convenient carrying options, they state in the company press release.
The OxySpur oxygen diffusion dressings have been updated with blue bubbles on the top in order to help identify the top, occlusive layer, of the dressing from the bottom, foam layer, allowing for easier at home dressing changes, guided by a clinician.
As the COVID-19 pandemic has impeded many patients from being able to attend their routine wound care appointments, EO2 Concepts and their CDO therapy has been able to offer physicians using telehealth programmes more at-home therapy to patients, especially in the New York City area.
“We are happy to continue offering full closure and pain relief to our patients treated at home during this pandemic who cannot get to the wound care centre,” says Joe Moffett, president and CEO of EO2 Concepts. “We are thankful for all of the wound care clinicians who continue to work through this crisis, and grateful that we could step in to help keep wound care patients out of the facilities emergency rooms.”
